Cannabinoid Receptor I (CNR1) Human shRNA Plasmid Kit (Locus ID 1268)

Specifications

Product Data
Product Name	Cannabinoid Receptor I (CNR1) Human shRNA Plasmid Kit (Locus ID 1268)
Locus ID	1268
UniProt ID	P21554
Synonyms	CANN6; CB-R; CB1; CB1A; CB1K5; CB1R; CNR
Vector	pRS
Format	Retroviral plasmids
Kit Components	CNR1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 1268). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free.
RefSeq	NM_001160226, NM_001160258, NM_001160259, NM_001160260, NM_001840, NM_016083, NM_033181, NM_016083.3, NM_016083.4, NM_033181.1, NM_033181.2, NM_033181.3, NM_001160226.1, NM_001160258.1, NM_001160259.1, NM_001160260.1, BC074811, BC074812, BC095513, BC100968, BC100969, BC100970, BC100971, BM682178, NM_001365872, NM_001370545, NM_001365869, NM_001365870, NM_001365874, NM_001370546, NM_001370547, NM_001160259.3, NM_001160258.3, NM_016083.6, NM_001160226.3
Summary	This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene. [provided by RefSeq, May 2009]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.